Prag, Hiran A. http://orcid.org/0000-0002-4753-8567
Murphy, Michael P. http://orcid.org/0000-0003-1115-9618
Krieg, Thomas http://orcid.org/0000-0002-5192-580X
Funding for this research was provided by:
British Heart Foundation (PG/20/10025)
Medical Research Council (MC_UU_00015/3)
Wellcome Trust (220257/z/20/z)
Article History
Received: 30 June 2023
Revised: 4 August 2023
Accepted: 6 August 2023
First Online: 28 August 2023
Declarations
:
: HAP, MPM and TK have pending patents on targeting succinate metabolism in ischaemia/reperfusion injury. MPM and TK are directors of Camoxis Therapeutics Ltd.